A Phase I Study to Determine the Maximum Tolerated Dose of Topotecan Following Oral Administration over 5, 10 or 21 Days in Patients with Malignant Solid Tumors

Update Il y a 4 ans
Reference: GSK104864/049

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract


Links